| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86761 |
DOTA-mono-NHS tris (t-Bu ester) Hydrogen Hexafluorophosphate |
97 |
wyh |
2024-11-22 |
| 86762 |
CAS：127985-74-4 p-SCN-Bn-DOTA |
101 |
zyl |
2024-11-22 |
| 86763 |
聚甲基硅次乙炔基硅烷（MSE） |
127 |
WYQ |
2024-11-22 |
| 86764 |
聚苯基二乙炔基苯硅烷（MSP） |
169 |
WYQ |
2024-11-22 |
| 86765 |
N,N-二炔丙基-3-乙炔基苯胺（DPEA） |
130 |
WYQ |
2024-11-22 |
| 86766 |
乙炔基封端的氢化超支化聚碳硅烷（EHBP） |
93 |
WYQ |
2024-11-22 |
| 86767 |
CAS：819869-77-7 DOTA-tris(tBu)ester NHS ester |
87 |
zyl |
2024-11-22 |
| 86768 |
CAS：180978-54-5 DOTA-Biotin-Sarcosine DOTA-生物素-肌氨酸 |
92 |
zyl |
2024-11-22 |
| 86769 |
端乙炔基聚醚酰亚胺改性硅芳炔树脂（PEI-PSA） |
108 |
WYQ |
2024-11-22 |
| 86770 |
DOTA 偶联肽,NOTA-E(cRGDfK)2,NOTA标记多肽氨基酸试剂 |
141 |
kx |
2024-11-22 |
| 86771 |
Lutetium (177Lu) oxodotreotide；437608-50-9 |
108 |
wyh |
2024-11-22 |
| 86772 |
CAS：2125661-62-1 Butyne-DOTA |
97 |
zyl |
2024-11-22 |
| 86773 |
端乙炔基聚醚酰亚胺（PEI）（Polyetherimide，简称PEI） |
222 |
WYQ |
2024-11-22 |
| 86774 |
碳/聚硅乙炔基防热复合材料（C/PMR） |
134 |
WYQ |
2024-11-22 |
| 86775 |
聚（间二乙炔基苯-甲基氢硅烷）树脂（PSA） |
269 |
WYQ |
2024-11-22 |
| 86776 |
P-氨基苯乙炔基共轭侧基的聚对苯撑乙炔（PAnPE） |
114 |
WYQ |
2024-11-22 |
| 86777 |
DOTA-G5 DOTA修饰修饰第5代(G5)聚(酰胺基胺)树枝状聚合物 |
125 |
zcy |
2024-11-22 |
| 86778 |
DOTA-PEG5-azide 大环化合物-五聚乙二醇-叠氮 |
93 |
zyl |
2024-11-22 |
| 86779 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, a-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester |
113 |
wyh |
2024-11-22 |
| 86780 |
DOTA功能化的聚赖氨酸 |
130 |
zcy |
2024-11-22 |
| 86781 |
聚乳酸-羟基乙酸共聚物-大环配体 |
129 |
wyh |
2024-11-22 |
| 86782 |
DOTA-Tyr3-thre8-奥曲肽 DOTA-Tyr3-Thre8-octreotide |
104 |
zcy |
2024-11-22 |
| 86783 |
1,4,7,10-Tetrakis(aminocarbonylmethyl)-1,4,7,10-tetraazacyclododecane |
93 |
wyh |
2024-11-22 |
| 86784 |
BKT140CXCR4 antagonist-DOTA |
105 |
zyl |
2024-11-22 |
| 86785 |
CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) |
109 |
zyl |
2024-11-22 |
| 86786 |
DOTA di(tBu)ester；913542-71-9 |
119 |
wyh |
2024-11-22 |
| 86787 |
10,10'-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸]，三氟乙酸盐；1175002-77-3 |
97 |
wyh |
2024-11-22 |
| 86788 |
(R)-tert-Bu4-DOTAGA；817562-90-6 |
111 |
wyh |
2024-11-22 |
| 86789 |
DOTA-Bevacizumab DOTA-贝伐单抗 |
114 |
zcy |
2024-11-22 |
| 86790 |
10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸，三氟乙酸盐 |
103 |
wyh |
2024-11-22 |
| 86791 |
DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac |
116 |
zcy |
2024-11-22 |
| 86792 |
DOTA-HYNIC-IPSMA |
111 |
wyh |
2024-11-22 |
| 86793 |
PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 |
263 |
zcy |
2024-11-22 |
| 86794 |
CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
94 |
zyl |
2024-11-22 |
| 86795 |
(S)-N-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYL)-6-(METHYL(3-(PIPERAZIN-1-YL)PROPYL)AMINO)QUINOLINE-4-CARBOXAMIDE |
115 |
wyh |
2024-11-22 |
| 86796 |
DOTA(Tris)-EA-TEG-NH2-CBZ DOTA(Tris)-乙胺(EA)偶联四甘醇(TEG) |
205 |
zcy |
2024-11-22 |
| 86797 |
DOTA-octreotide,大环配体奥曲肽 |
133 |
zyl |
2024-11-22 |
| 86798 |
N2-Acetyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-lysyl-L-prolyl-N2-methyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-3-methyl-L-valyl-L-leucine |
94 |
wyh |
2024-11-22 |
| 86799 |
DOTA-Ts29.2 DOTA偶联单克隆抗体Ts29.2 |
121 |
zcy |
2024-11-22 |
| 86800 |
DOTA-FAMP α螺旋肽偶联DOTA大环配体 |
114 |
zcy |
2024-11-22 |
| 86801 |
DOTA-NT8-13(靶向NTR1) |
118 |
zcy |
2024-11-22 |
| 86802 |
DOTA Conjugated JM#21 derivative 7 ；3033865-40-3 |
131 |
wyh |
2024-11-22 |
| 86803 |
4-Aminobutyl-DOTA-tris(t-butyl ester) Hexafluorophosphate |
93 |
wyh |
2024-11-22 |
| 86804 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
91 |
wyh |
2024-11-22 |
| 86805 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
98 |
wyh |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询